3059 related articles for article (PubMed ID: 19298974)
21. Functional outcomes following percutaneous surgery in the solitary kidney.
Canes D; Hegarty NJ; Kamoi K; Haber GP; Berger A; Aron M; Desai MM
J Urol; 2009 Jan; 181(1):154-60. PubMed ID: 19013616
[TBL] [Abstract][Full Text] [Related]
22. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
23. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
[TBL] [Abstract][Full Text] [Related]
24. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
26. Impact of tumor size on renal function and prediction of renal insufficiency after radical nephrectomy in patients with renal cell carcinoma.
Ohno Y; Nakashima J; Ohori M; Hashimoto T; Iseki R; Hatano T; Tachibana M
J Urol; 2011 Oct; 186(4):1242-6. PubMed ID: 21849191
[TBL] [Abstract][Full Text] [Related]
27. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
[TBL] [Abstract][Full Text] [Related]
28. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
[TBL] [Abstract][Full Text] [Related]
29. Imperative and elective indications for nephron-sparing surgery for renal tumors: long-term oncological follow-up.
Roos FC; Pahernik S; Brenner W; Thüroff JW
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S70-6. PubMed ID: 20094960
[TBL] [Abstract][Full Text] [Related]
30. Minimally invasive nephron sparing management for renal tumors in solitary kidneys.
Turna B; Kaouk JH; Frota R; Stein RJ; Kamoi K; Gill IS; Novick AC
J Urol; 2009 Nov; 182(5):2150-7. PubMed ID: 19758655
[TBL] [Abstract][Full Text] [Related]
31. Impact of temporary hilar clamping during laparoscopic partial nephrectomy on postoperative renal function: a prospective study.
Shekarriz B; Shah G; Upadhyay J
J Urol; 2004 Jul; 172(1):54-7. PubMed ID: 15201736
[TBL] [Abstract][Full Text] [Related]
32. A postoperative prognostic nomogram for renal cell carcinoma.
Kattan MW; Reuter V; Motzer RJ; Katz J; Russo P
J Urol; 2001 Jul; 166(1):63-7. PubMed ID: 11435824
[TBL] [Abstract][Full Text] [Related]
33. Tailoring technique of laparoscopic partial nephrectomy to tumor characteristics.
Weizer AZ; Gilbert SM; Roberts WW; Hollenbeck BK; Wolf JS
J Urol; 2008 Oct; 180(4):1273-8. PubMed ID: 18707711
[TBL] [Abstract][Full Text] [Related]
34. Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients.
Lapini A; Serni S; Minervini A; Masieri L; Carini M
J Urol; 2005 Jul; 174(1):57-60; discussion 60. PubMed ID: 15947577
[TBL] [Abstract][Full Text] [Related]
35. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
[TBL] [Abstract][Full Text] [Related]
36. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
37. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Jonasch E; Merchant MM; Spiess PE; Wood CG
Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic partial nephrectomy: single center experience with 140 patients--evolution of the surgical technique and its impact on patient outcomes.
Nadu A; Mor Y; Laufer M; Winkler H; Kleinmann N; Kitrey N; Ramon J
J Urol; 2007 Aug; 178(2):435-9; discussion 438-9. PubMed ID: 17561145
[TBL] [Abstract][Full Text] [Related]
39. Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up.
Denzinger S; Ganzer R; Fink A; Wieland WF; Blana A
Scand J Urol Nephrol; 2007; 41(6):496-500. PubMed ID: 17853016
[TBL] [Abstract][Full Text] [Related]
40. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
Carini M; Minervini A; Lapini A; Masieri L; Serni S
J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
